Samuel Lai

Chameleon Biosciences, Inc. engages in the provision of a pre-clinical stage gene therapy. The company was founded by Genine Winslow and Jeffery Scott Vick and is headquartered in Berkeley, CA.

EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California.

ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.

Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey.

Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA.

Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA.

Saccharo, Inc. is a biotech startup located in Oakland, CA. The company is focused on developing products for a novel polysaccharide target found only on cancer cells, not on normal cells, which is constant across all stages and types of cancer. This target is involved in a unique immune shielding pathway and serves as a platform for multiple drug modalities. Sheryl Martin-Moe has been the CEO of the company since 2017.

Kryptos Biotechnologies, Inc engages in the development of life science tools that capture genuine status of each cell to present unbiased genomic characteristics. The company was founded by Jin Yong Lee and Jun Ho Son in 2017 and is headquartered in Hayward, CA.

Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA.

DxUpClose, Inc. develops a point-of-care bacterial diagnostic antibiotic sensitivity test. The company was founded by Cyndi Nickel, James Biard and Clois Powell and is headquartered in Frisco, TX.